Literature DB >> 19256503

Hit to lead account of the discovery of a new class of inhibitors of Pim kinases and crystallographic studies revealing an unusual kinase binding mode.

Kevin Qian1, Lian Wang, Charles L Cywin, Bennett T Farmer, Eugene Hickey, Carol Homon, Scott Jakes, Mohammed A Kashem, George Lee, Scott Leonard, Jun Li, Ronald Magboo, Wang Mao, Edward Pack, Charlene Peng, Anthony Prokopowicz, Morgan Welzel, John Wolak, Tina Morwick.   

Abstract

A series of inhibitors of Pim-2 kinase identified by high-throughput screening is described. Details of the hit validation and lead generation process and structure-activity relationship (SAR) studies are presented. Disclosure of an unconventional binding mode for 1, as revealed by X-ray crystallography using the highly homologous Pim-1 protein, is also presented, and observed binding features are shown to correlate with the Pim-2 SAR. While highly selective within the kinase family, the series shows similar potency for both Pim-1 and Pim-2, which was expected on the basis of homology, but unusual in light of reports in the literature documenting a bias for Pim-1. A rationale for these observations based on Pim-1 and Pim-2 K(M(ATP)) values is suggested. Some interesting cross reactivity with casein kinase-2 was also identified, and structural features which may contribute to the association are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19256503     DOI: 10.1021/jm801242y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  Pim-2 activates API-5 to inhibit the apoptosis of hepatocellular carcinoma cells through NF-kappaB pathway.

Authors:  Ke Ren; Wei Zhang; Yujun Shi; Jianping Gong
Journal:  Pathol Oncol Res       Date:  2009-10-12       Impact factor: 3.201

Review 2.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

Review 3.  PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers.

Authors:  Laurent Brault; Christelle Gasser; Franz Bracher; Kilian Huber; Stefan Knapp; Jürg Schwaller
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

4.  Identification of quinones as novel PIM1 kinase inhibitors.

Authors:  Richard L Schroeder; Navneet Goyal; Melyssa Bratton; Ian Townley; Nancy A Pham; Phan Tram; Treasure Stone; Jasmine Geathers; Kathy Nguyen; Jayalakshmi Sridhar
Journal:  Bioorg Med Chem Lett       Date:  2016-04-28       Impact factor: 2.823

5.  Pim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cells.

Authors:  Zeping Wang; Yandong Zhang; Juan Jenny Gu; Christine Davitt; Raymond Reeves; Nancy S Magnuson
Journal:  Int J Biochem Cell Biol       Date:  2010-03-20       Impact factor: 5.085

6.  Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion.

Authors:  Niina M Santio; Riitta L Vahakoski; Eeva-Marja Rainio; Jouko A Sandholm; Sanna S Virtanen; Michelle Prudhomme; Fabrice Anizon; Pascale Moreau; Päivi J Koskinen
Journal:  Mol Cancer       Date:  2010-10-19       Impact factor: 27.401

7.  Discovery and identification of PIM-1 kinase inhibitors through a hybrid screening approach.

Authors:  Mingfeng Shao; Yiming Yuan; Kun Yu; Kai Lei; Guonian Zhu; Lijuan Chen; Mingli Xiang
Journal:  Mol Divers       Date:  2014-02-12       Impact factor: 2.943

Review 8.  The essential roles of chemistry in high-throughput screening triage.

Authors:  Jayme L Dahlin; Michael A Walters
Journal:  Future Med Chem       Date:  2014-07       Impact factor: 3.808

9.  Flexibility of the P-loop of Pim-1 kinase: observation of a novel conformation induced by interaction with an inhibitor.

Authors:  Lorien J Parker; Hisami Watanabe; Keiko Tsuganezawa; Yuri Tomabechi; Noriko Handa; Mikako Shirouzu; Hitomi Yuki; Teruki Honma; Naoko Ogawa; Tetsuo Nagano; Shigeyuki Yokoyama; Akiko Tanaka
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-07-31

10.  The design and application of target-focused compound libraries.

Authors:  C John Harris; Richard D Hill; David W Sheppard; Martin J Slater; Pieter F W Stouten
Journal:  Comb Chem High Throughput Screen       Date:  2011-07       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.